Randomized Multicenter Placebo-Controlled Trial of Omega-3 Fatty Acids for the Control of Aromatase Inhibitor–Induced Musculoskeletal Pain: SWOG S0927

PURPOSE: Musculoskeletal symptoms are the most common adverse effects of aromatase inhibitors (AIs) and can result in decreased quality of life and discontinuation of therapy. Omega-3 fatty acids (O3-FAs) can be effective in decreasing arthralgia resulting from rheumatologic conditions and reducing...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Clin Oncol
Prif Awduron: Hershman, Dawn L., Unger, Joseph M., Crew, Katherine D., Awad, Danielle, Dakhil, Shaker R., Gralow, Julie, Greenlee, Heather, Lew, Danika L., Minasian, Lori M., Till, Cathee, Wade, James L., Meyskens, Frank L., Moinpour, Carol M.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Society of Clinical Oncology 2015
Pynciau:
ORIGINAL REPORTS
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4451174/
https://ncbi.nlm.nih.gov/pubmed/25940724
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2014.59.5595
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg